Cite
Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum
MLA
Jing, Liu, et al. “Rapamycin Inhibits Peritoneal Fibrosis by Modifying Lipid Homeostasis in the Peritoneum.” American Journal of Translational Research, vol. 11, no. 3, Oct. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........b45fefc6d90fe4fb4e9967a95bacd565&authtype=sso&custid=ns315887.
APA
Jing, L., Chun-Ming, J., Yuan, F., Wei, Z., Bo, J., Yang-Yang, X., Qing-Yan, Z., Peng-Fei, X., & Miao, Z. (2018). Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum. American Journal of Translational Research, 11(3).
Chicago
Jing, Liu, Jiang Chun-Ming, Feng Yuan, Zhu Wei, Jin Bo, Xia Yang-Yang, Zhang Qing-Yan, Xu Peng-Fei, and Zhang Miao. 2018. “Rapamycin Inhibits Peritoneal Fibrosis by Modifying Lipid Homeostasis in the Peritoneum.” American Journal of Translational Research 11 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........b45fefc6d90fe4fb4e9967a95bacd565&authtype=sso&custid=ns315887.